How Vif Protein Helps HIV-1 Overcome Drug Inhibition
Author Information
Author(s): DaFonseca Sandrina, Coric Pascale, Gay Bernard, Hong Saw See, Bouaziz Serge, Boulanger Pierre
Primary Institution: Université de Lyon I – Claude Bernard
Hypothesis
Can viral proteins modulate the susceptibility of HIV-1 to the drug DSB?
Conclusion
The Vif protein of HIV-1 can counteract the inhibitory effects of DSB on virus-like particle assembly, depending on its zinc-binding domain.
Supporting Evidence
- Vif protein restored VLP production in DSB-treated cells to control levels.
- Vif mutants lacking the zinc-binding domain could not counteract DSB's effects.
- Electron microscopy showed VLP were redirected to vesicular compartments in the presence of Vif.
Takeaway
A protein called Vif helps HIV-1 fight against a drug that tries to stop it from making new virus particles. If Vif is damaged, the drug works better.
Methodology
The study involved coexpressing viral proteins with HIV-1 Gag in insect cells and assessing the effects of DSB on virus-like particle assembly.
Limitations
The study was conducted in insect cells, which may not fully replicate human cellular responses.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website